您当前的位置：
首页 >
文章列表页 >
Analysis of dilemmas and recommendations for value assessment of antitumor combination therapies
更新时间：2026-06-10

    • Analysis of dilemmas and recommendations for value assessment of antitumor combination therapies

    • ZHONGGUO YAOFANG   Vol. 37, Issue 11, Pages: 1447-1451(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.11.11    

      CLC： R956

    • Received：30 January 2026，

      Revised：2026-05-29，

      Accepted：30 May 2026，

      Published：15 June 2026

    移动端阅览

  • WANG Xuerong,ZHOU Ting,LI Yan,et al.Analysis of dilemmas and recommendations for value assessment of antitumor combination therapies[J].ZHONGGUO YAOFANG,2026,37(11):1447-1451. DOI： 10.6039/j.issn.1001-0408.2026.11.11.

  •  
  •  

0

Views

14

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Cause Analysis of “Not Cost-effective at a Zero Price ”Results in Pharmacoeconomic Evaluation
Long-term clinical effectiveness and cost-effectiveness of 10 first-line antiretroviral therapy regimens for HIV-infected patients in China
Construction of hospital preparation cost item library based on the Delphi method
Pharmacoeconomic evaluation of culmerciclib combined with fulvestrant in the second-line treatment of HR+/HER2－ locally advanced or metastatic breast cancer
Pharmacoeconomic evaluation of zolbetuximab combined with chemotherapy as first-line treatment for CLDN18.2-positive and HER2-negative advanced gastric cancer

Related Author

GUAN Xin
WANG Luying
LI Hongchao
ZHOU Kejia
ZHOU Dachuang
TANG Wenxi
OU Shunlong
LIN Hong

Related Institution

Dept. of Pharmacy， Sichuan Cancer Hospital （Institute）/Sichuan Clinical Research Center for Cancer/Sichuan Cancer Prevention and Control Center/Affiliated Cancer Hospital of University of Electronic Science and Technology of China
Dept. of Clinical Pharmacy， West China Hospital， Sichuan University
Dept. of Pharmacy， Hebei Medical University Third Hospital
School of Graduate， Hebei Medical University
Hebei Society for Integrated Drug and Health Technology Assessment
0